Shelia was most recently Director in Immunology at Biogen Idec and previously the Research Head for the Fibrosis focus area and project leader for the αvβ6 program. Prior to Biogen Idec, Shelia worked at ARIAD Pharmaceuticals and Repligen and has extensive experience from discovery to preclinical development in multiple therapeutic areas.
